tirzepatide levothyroxine Black Box Warning of Risk of thyroid C-cell tumors ๐It is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent Tirzepatide and Thyroid Medication Interactions
Description
Well please with my experience

Long-term considerations and realistic expectations Tirzepatide is not a magic injection

The general guidance is to increase the dose only when weight loss has plateaued at the current level and side effects are manageable

Here is the timeline of average weight loss: 12 weeks: -20.12 pounds 24 weeks: -35.67 pounds 36 weeks: -47.33 pounds 52 weeks (1 year): -52.28 pounds 72 weeks (18 months): -62.79 pounds (-26.54% body weight) These are averages, which means individual results varied

Related Reading What Determines If You Are A Morning Person Or A Night Owl Can You Avoid Diabetes If It Runs In Your Family Hers Mounjaro Hims Mounjaro Pricing and availability current as of July 2026

E.G.V., A.D.A., P.S., J.P.D., C.S., and C.J.L
